Star Imaging and Path Lab Ltd Financial Ratios
STARIMAGIN · Healthcare Services · Current price ₹69.1
P/E ratio
6.3x
P/B ratio
1.2x
ROE
16.6%
ROCE
20.6%
Debt / Equity
0.18
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 6.3x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.2x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 20.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.18 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Star Imaging and Path Lab Ltd's latest numbers.
Star Imaging and Path Lab Ltd profitability
Star Imaging and Path Lab Ltd generates a return on equity of 16.6% and a return on capital employed of 20.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.18 and a P/E of 6.3x, Star Imaging and Path Lab Ltd is conservatively financed. Our overall business-quality score for the company is 6.6 / 10.
Understand the ratios
More on Star Imaging and Path Lab Ltd
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.